Johnson & Johnson Reaches $5.5 Billion Settlement
On Monday, Johnson & Johnson (J&J) announced that it has reached an estimated settlement of $5.5 billion to address tens of thousands of lawsuits. These lawsuits allege that the company’s baby powder and talc products may cause ovarian cancer, potentially bringing an end to years of legal disputes.
The proposed settlement aims to cover nearly all outstanding claims against J&J, involving about 76,000 claims that include consolidated actions in federal court in New Jersey and related cases in state court.
Previously, J&J had settled many lawsuits claiming that its talc contained asbestos and led to mesothelioma.
The law firm representing the plaintiffs confirmed the settlement, expressing that it is a positive outcome after a decade of legal battles. For this agreement to become official, 95% of those with ovarian cancer claims must consent to it in either state or federal court.
In the announcement, J&J denied any wrongdoing, arguing that plaintiffs had failed to prove their case that the talc products caused harm. They cited the settlement as a practical way to end ongoing litigation.
Eric Haas, J&J’s Worldwide Vice President of Litigation, remarked that, “While we are confident that ultimately we would have prevailed in additional cases, just as we have in the majority of previous litigation attempts, this resolution allows us to move forward and focus on our mission to develop life-saving medicines and devices.”
The company plans to distribute $3 billion in 2027, with additional payments in 2028. However, depending on participation, the total payout could exceed $7 billion since there is no cap on the total payment allocated for ovarian cancer claims.
Chris Seeger, an attorney representing approximately 2,500 clients in the talc claims, stated that the settlement is fair and likely to please the affected customers.
This announcement follows a series of court victories for J&J, including individual cases and rulings against the plaintiffs’ legal representatives. A recent court decision raised doubts about whether individual plaintiffs could definitively link talc to ovarian cancer.
J&J has consistently denied that its talc products are cancer-causing, maintaining that they are safe and free of asbestos. In 2020, the company stopped selling talc-based baby powder in the U.S. and switched to cornstarch alternatives.
The company previously sought to resolve the lawsuit through a bankruptcy strategy involving a subsidiary, but that approach was unsuccessful.
While this settlement addresses existing claims, it does not cover future litigation. Excluding future claims is expected to allow for quicker payments to current claimants and ensures that all claims will be settled within 18 months, rather than over an extended period.
